Insulet reported $1.37B in Loan Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Atricure ATRC:US USD 65.98M 3.49M
Baxter International BAX:US USD 15.23B 921M
Becton, Dickinson and BDX:US USD 14.27B 382M
Cardinal Health CAH:US USD 4.69B 4M
Cardiovascular Systems CSII:US USD 20.12M 91K
Cooper Companies COO:US USD 2.63B 276.5M
Dexcom DXCM:US USD 1.26B 771.9M
Edwards Lifesciences EW:US USD 596.3M 100K
Icu Medical ICUI:US USD 1.63B 6.01M
Insulet PODD:US USD 1.37B 5.5M
Integra Lifesciences IART:US USD 1.41B 81.95M
Masimo MASI:US USD 941.6M 9.8M
Medtronic MDT:US USD 22.21B 1.46B
Merit Medical Systems MMSI:US USD 186.76M 18.65M
Nuvasive NUVA:US USD 445.07M 719K
Roche Holding ROG:VX 21.39B 978M
Sientra SIEN:US USD 70.07M 6.99M
Stryker SYK:US USD 11.86B 894M
Tandem Diabetes Care TNDM:US USD 283.23M 445K
Teleflex TFX:US USD 1.62B 30.52M
West Pharmaceutical Services WST:US USD 208.9M 1.7M
Zimmer Biomet Holdings Inc ZBH:US USD 5.15B 97M